EP3256447B1 - Composés 2-oxo-3,4-dihydroquinoléine à utiliser en tant que régulateurs de croissance des plantes - Google Patents

Composés 2-oxo-3,4-dihydroquinoléine à utiliser en tant que régulateurs de croissance des plantes Download PDF

Info

Publication number
EP3256447B1
EP3256447B1 EP16703127.7A EP16703127A EP3256447B1 EP 3256447 B1 EP3256447 B1 EP 3256447B1 EP 16703127 A EP16703127 A EP 16703127A EP 3256447 B1 EP3256447 B1 EP 3256447B1
Authority
EP
European Patent Office
Prior art keywords
alkyl
methyl
oxo
plant
dihydroquinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP16703127.7A
Other languages
German (de)
English (en)
Other versions
EP3256447A1 (fr
Inventor
Mathilde Denise Lachia
Olivier Loiseleur
Sebastian Volker Wendeborn
Pierre Joseph Marcel Jung
Davide SABBADIN
Andreas Beck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Participations AG
Original Assignee
Syngenta Participations AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1502067.0A external-priority patent/GB201502067D0/en
Priority claimed from GBGB1509129.1A external-priority patent/GB201509129D0/en
Application filed by Syngenta Participations AG filed Critical Syngenta Participations AG
Priority to PL16703127T priority Critical patent/PL3256447T3/pl
Publication of EP3256447A1 publication Critical patent/EP3256447A1/fr
Application granted granted Critical
Publication of EP3256447B1 publication Critical patent/EP3256447B1/fr
Priority to HRP20191504 priority patent/HRP20191504T1/hr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • the present invention relates to novel sulfonamide derivatives, to processes and intermediates for preparing them, to plant growth regulator compositions comprising them and to methods of using them for controlling the growth of plants, improving plant tolerance to abiotic stress (including environmental and chemical stresses), inhibiting seed germination and/or safening a plant against phytotoxic effects of chemicals.
  • Abscisic acid is a plant hormone that plays a major role in plant growth, development and response to abiotic stress.
  • ABA causes many of its cellular responses by binding to a soluble family of receptors called PYR/PYL proteins, which contain a ligand-binding pocket for ABA and other agonists.
  • PYR/PYL proteins a soluble family of receptors
  • Direct application of ABA to plants has been shown to improve their water use efficiency.
  • ABA is difficult and expensive to prepare and itself unstable to environmental conditions and therefor unsuitable for large scale agricultural applications. It is therefore desirable to search for ABA agonists that may be useful for improving plant tolerance to environment stress such as drought, inhibit seed germination, regulate plant growth and improve crop yield.
  • WO2013/148339 reported a new ABA agonist, quinabactin, which binds to the PYR/PRL receptor proteins and causes an abscisic acid response in vivo .
  • Quinabactin has been shown to induce stomatal closure, suppress water loss and promote drought tolerance.
  • the present invention relates to novel analogs of quinabactin that have improved properties.
  • Benefits of the compounds of the present invention include enhanced tolerance to abiotic stress, improved inhibition of seed germination, better regulation of crop growth, improved crop yield, and/or improved physical properties resulting in better plant uptake, water solubility, chemical stability or physical stability.
  • the compounds of the present invention may exist in different geometric or optical isomers (diastereoisomers and enantiomers) or tautomeric forms.
  • This invention covers all such isomers and tautomers and mixtures thereof in all proportions as well as isotopic forms such as deuterated compounds.
  • the invention also covers all salts, N-oxides, and metalloidic complexes of the compounds of the present invention.
  • Each alkyl moiety either alone or as part of a larger group is a straight or branched chain and is, for example, methyl, ethyl, n -propyl, n -butyl, n -pentyl, n -hexyl, iso -propyl, n -butyl, sec -butyl, iso- butyl, tert -butyl or neo -pentyl.
  • the alkyl groups include C 1 - C 6 alkyl, C 1 -C 4 alkyl, and C 1 -C 3 alkyl.
  • alkenyl is an alkyl moiety having at least one carbon-carbon double bond, for example C 2 - C 6 alkenyl. Specific examples include vinyl and allyl.
  • the alkenyl moiety may be part of a larger group (such as alkenoxy, alkenoxycarbonyl, alkenylcarbonyl, alkyenlaminocarbonyl, dialkenylaminocarbonyl).
  • alkynyl is an alkyl moiety having at least one carbon-carbon triple bond, for example C 2 - C 6 alkynyl. Specific examples include ethynyl and propargyl.
  • the alkynyl moiety may be part of a larger group (such as alkynoxy, alkynoxycarbonyl, alkynylcarbonyl, alkynylaminocarbonyl, dialkynylaminocarbonyl).
  • Halogen is fluorine (F), chlorine (Cl), bromine (Br) or iodine (I).
  • Haloalkyl groups are alkyl groups which are substituted with one or more of the same or different halogen atoms and are, for example, -CF 3 , -CF 2 Cl, -CH 2 CF 3 or -CH 2 CHF 2 .
  • Hydroxyalkyl groups are alkyl groups which are substituted with one or more hydroxyl group and are, for example, -CH 2 OH, -CH 2 CH 2 OH or -CH(OH)CH 3 .
  • Alkoxyalkyl groups are an alkoxy group bonded to an alkyl (R-O-R'), for example -(CH 2 ) r O(CH 2 ) s CH 3 , wherein r is 1 to 6 and s is 1 to 5.
  • aryl refers to a ring system which may be mono-, bi- or tricyclic. Examples of such rings include phenyl, naphthalenyl, anthracenyl, indenyl or phenanthrenyl.
  • alkenyl and alkynyl on their own or as part of another substituent, may be straight or branched chain and may contain 2 to 6 carbon atoms, and where appropriate, may be in either the ( E )- or ( Z )-configuration. Examples include vinyl, allyl, ethynyl and propargyl.
  • cycloalkyl may be mono- or bi-cyclic, may be optionally substituted by one or more C 1 -C 6 alkyl groups, and contain 3 to 7 carbon atoms.
  • Examples of cycloalkyl include cyclopropyl, 1-methylcyclopropyl, 2-methylcyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
  • heterocyclyl refers to a ring system containing from one to four heteroatoms selected from N, O and S, wherein the nitrogen and sulphur atoms are optionally oxidized, and the nitrogen atom(s) are optionaly quaternized.
  • Heterocyclyl includes heteroaryl, saturated analogs, and in addition their unsaturated or partially unsaturated analogues such as 4,5,6,7-tetrahydro-benzothiophenyl, 9H-fluorenyl, 3,4-dihydro-2H-benzo-1,4-dioxepinyl, 2,3-dihydro-benzofuranyl, piperidinyl, 1,3-dioxolanyl, 1,3-dioxanyl, 4,5-dihydro-isoxazolyl, tetrahydrofuranyl and morpholinyl.
  • analogues such as 4,5,6,7-tetrahydro-benzothiophenyl, 9H-fluorenyl, 3,4-dihydro-2H-benzo-1,4-dioxepinyl, 2,3-dihydro-benzofuranyl, piperidinyl, 1,3-dioxolanyl,
  • heterocyclyl includes heterocycloalkyl, a non-aromatic monocyclic or polycyclic ring comprising carbon and hydrogen atoms and at least one heteroatom selected from nitrogen, oxygen, and sulfur such asoxetanyl or thietanyl.
  • heteroaryl refers to an aromatic ring system containing from one to four heteroatoms selected from N, O, and S, wherein the nitrogen and sulfur atoms are optionally oxidized, and consisting either of a single ring or of two or more fused rings.
  • Single rings may contain up to three heteroatoms, and bicyclic systems up to four heteroatoms, which will preferably be chosen from nitrogen, oxygen and sulfur.
  • Examples of such groups include pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, furanyl, thienyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl and tetrazolyl.
  • R1, R2, R3, R4, R5, R6, R7, R8, L, A, Rx, Ry and Rz are, in any combination, as set out below.
  • R1 is selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 3 -C 5 cycloalkyl-C 1 -C 6 alkyl, C 3 -C 6 alkenyl, C 3 -C 6 alkynyl, phenyl and a 4-6 membered heterocyclyl, each optionally substituted with one to three Rx.
  • R1 is selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 3 -C 6 alkenyl and C 3 -C 5 -cycloalkyl-C 1 -C 6 alkyl.
  • R1 is selected from the group consisting of C 1 -C 6 alkyl, C 3 -C 5 alkenyl, C 3 -C 5 -cycloalkyl-C 1 -C 2 alkyl and C 2 -C 4 haloalkyl.
  • R1 is ethyl, isopropyl, n-propyl, allyl, cyclopropyl-methyl or 2,2,2-trifluoro-ethyl.
  • the alkyl chain may be branched or linear.
  • R1 is methyl.
  • R1 is ethyl.
  • R1 is n-propyl or iso-propyl.
  • R1 is n- butyl, iso- butyl, sec- butyl or tert- butyl.
  • R1 is allyl, cyclopropyl-methyl or 2,2,2-trifluoro-ethyl.
  • R2 is selected from the group consisting of hydrogen, C 1 -C 4 alkyl and C 1 -C 4 alkoxy.
  • R2 is selected from the group consisting of hydrogen and C 1 -C 4 alkyl.
  • R3 is selected from the group consisting of hydrogen, halogen, cyano, C 1 -C 4 alkyl and C 1 -C 4 alkoxy.
  • R3 is selected from the group consisting of hydrogen, halogen and C 1 -C 4 alkyl.
  • each of R4 and R5 are independently selected from the group consisting of hydrogen and C 1 -C 4 alkyl.
  • each of R4 and R5 is independently hydrogen or methyl.
  • R6 is hydrogen
  • each of R7 and R8 are independently selected from the group consisting of hydrogen, halogen, cyano, C 1 -C 4 alkyl and C 1 -C 4 alkoxy.
  • L is selected from the group consisting of a bond, a linear -C 1 -C 4 - alkyl chain, a linear -C 2 -C 4 - alkenyl chain, and a linear -C 2 -C 4 - alkynyl chain.
  • L is a bond.
  • L is a linear -C 1 -C 4 - alkyl chain.
  • L is a -C 2 -C 4 - alkenyl chain.
  • A is selected from the group consisting of C 1 -C 7 alkyl, phenyl and 3-6 membered heteroaryl, each optionally substituted with one to three Ry.
  • A is a 5-6 membered heteroaryl or phenyl, each optionally substituted with one to three Ry.
  • A is phenyl optionally substituted with one to three substituents independently selected from the group consisting of halogen, cyano, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 4 haloalkoxy, C 1 -C 4 haloalkylsulfanyl and C 3 -C 4 cycloalkyl.
  • A is phenyl optionally substituted with one to three substituents independently selected from the group consisting of halogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl and C 1 -C 4 haloalkoxy. In one embodiment, A is phenyl.
  • A is a 5-6 membered heteroaryl selected from the group consisting of pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, furanyl, thienyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl and tetrazolyl.
  • A is thienyl optionally substituted with one to three substituents independently selected from the group consisting of halogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl and C 1 -C 4 haloalkoxy.
  • Rx is selected from the group consisting of halogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl and C 1 -C 4 alkoxy.
  • Rx is selected from the group consisting of halogen and C 1 -C 4 alkyl.
  • Rx is halogen.
  • Rx is methyl.
  • Rx is ethyl.
  • Ry is selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 4 haloalkoxy, C 1 -C 4 haloalkylsulfanyl and C 3 -C 4 cycloalkyl.
  • Ry is selected from the group consisting of halogen, C 1 -C 4 haloalkyl and C 1 -C 4 alkyl.
  • Ry is selected from the group consisting of cyano, methyl, ethyl, cyclopropyl, trifluoromethyl, difluoromethyl, trifluoromethyloxy, difluoromethyloxy and trifluoromethylsulfanyl.
  • each Ry is selected from the group consisting of halogen, cyano, methyl, ethyl, propyl, cyclopropyl and butyl.
  • each Ry is selected from the group consisting of F, Cl, and Br.
  • Ry is fluoro.
  • Ry is difluoromethyl.
  • Ry is trifluoromethyl.
  • Ry is C 1 -C 4 haloalkylsulfanyl.
  • Rz is selected from the group consisting of halogen and C 1 -C 4 -alkyl. In one embodiment, Rz is halogen.
  • R1, R2, R3, R4, R5, R6, R7, R8, A, Rx, Ry and Rz for compounds of formula (IV) are, in any combination, as set out above.
  • Table 1 below includes examples of compounds of the present invention. TABLE 1 Each of the following structures may be combined with the substituent combinations listed in the table below, such that specific compound 1.001 is structure 1.xxx combined with compound x.001, specific compound 5.123 is structure 5.xxx combined with compound x.123 in the table, and so on.
  • the compounds of the present invention are applied in combination with an agriculturally acceptable adjuvant.
  • an agriculturally acceptable adjuvant comprising a compound of the present invention and an agriculturally acceptable adjuvant.
  • an agrochemical composition comprising a compound of the present invention.
  • the present invention provides a method of improving the tolerance of a plant to abiotic stress, wherein the method comprises applying to the plant, plant part, plant propagation material, or plant growing locus a compound, composition or mixture according to the present invention.
  • the present invention provides a method for regulating or improving the growth of a plant, wherein the method comprises applying to the plant, plant part, plant propagation material, or plant growing locus a compound, composition or mixture according to the present invention.
  • plant growth is regulated or improved when the plant is subject to abiotic stress conditions.
  • the present invention also provides a method for inhibiting seed germination of a plant, comprising applying to the seed, or a locus containing seeds, a compound, composition or mixture according to the present invention.
  • the present disclosure also provides a method for safening a plant against phytotoxic effects of chemicals, comprising applying to the plant, plant part, plant propagation material, or plant growing locus a compound, composition or mixture according to the present invention.
  • the compound or composition is applied in an amount sufficient to elicit the desired response.
  • regulating or improving the growth of a crop means an improvement in plant vigour, an improvement in plant quality, improved tolerance to stress factors, and/or improved input use efficiency.
  • An 'improvement in plant vigour' means that certain traits are improved qualitatively or quantitatively when compared with the same trait in a control plant which has been grown under the same conditions in the absence of the method of the invention.
  • Such traits include, but are not limited to, early and/or improved germination, improved emergence, the ability to use less seeds, increased root growth, a more developed root system, increased root nodulation, increased shoot growth, increased tillering, stronger tillers, more productive tillers, increased or improved plant stand, less plant verse (lodging), an increase and/or improvement in plant height, an increase in plant weight (fresh or dry), bigger leaf blades, greener leaf colour, increased pigment content, increased photosynthetic activity, earlier flowering, longer panicles, early grain maturity, increased seed, fruit or pod size, increased pod or ear number, increased seed number per pod or ear, increased seed mass, enhanced seed filling, less dead basal leaves, delay of senescence, improved vitality of the plant, increased levels of amino acids in storage tissues and/or less inputs
  • An 'improvement in plant quality' means that certain traits are improved qualitatively or quantitatively when compared with the same trait in a control plant which has been grown under the same conditions in the absence of the method of the invention.
  • Such traits include, but are not limited to, improved visual appearance of the plant, reduced ethylene (reduced production and/or inhibition of reception), improved quality of harvested material, e.g. seeds, fruits, leaves, vegetables (such improved quality may manifest as improved visual appearance of the harvested material), improved carbohydrate content (e.g. increased quantities of sugar and/or starch, improved sugar acid ratio, reduction of reducing sugars, increased rate of development of sugar), improved protein content, improved oil content and composition, improved nutritional value, reduction in anti-nutritional compounds, improved organoleptic properties (e.g.
  • a plant with improved quality may have an increase in any of the aforementioned traits or any combination or two or more of the aforementioned traits.
  • An 'improved tolerance to stress factors' means that certain traits are improved qualitatively or quantitatively when compared with the same trait in a control plant which has been grown under the same conditions in the absence of the method of the invention.
  • Such traits include, but are not limited to, an increased tolerance and/or resistance to biotic and/or abiotic stress factors, and in particular abiotic stress factors which cause sub-optimal growing conditions such as drought (e.g. any stress which leads to a lack of water content in plants, a lack of water uptake potential or a reduction in the water supply to plants), cold exposure, heat exposure, osmotic stress, UV stress, flooding, increased salinity (e.g.
  • a plant with improved tolerance to stress factors may have an increase in any of the aforementioned traits or any combination or two or more of the aforementioned traits. In the case of drought and nutrient stress, such improved tolerances may be due to, for example, more efficient uptake, use or retention of water and nutrients. In particular, the compounds or compositions of the present invention are useful to improve tolerance to drought stress.
  • An 'improved input use efficiency' means that the plants are able to grow more effectively using given levels of inputs compared to the grown of control plants which are grown under the same conditions in the absence of the method of the invention.
  • the inputs include, but are not limited to fertiliser (such as nitrogen, phosphorous, potassium, micronutrients), light and water.
  • a plant with improved input use efficiency may have an improved use of any of the aforementioned inputs or any combination of two or more of the aforementioned inputs.
  • any or all of the above crop enhancements may lead to an improved yield by improving e.g. plant physiology, plant growth and development and/or plant architecture.
  • 'yield' includes, but is not limited to, (i) an increase in biomass production, grain yield, starch content, oil content and/or protein content, which may result from (a) an increase in the amount produced by the plant per se or (b) an improved ability to harvest plant matter, (ii) an improvement in the composition of the harvested material (e.g.
  • Improved sugar acid ratios means that, where it is possible to take a quantitative measurement, the yield of a product of the respective plant is increased by a measurable amount over the yield of the same product of the plant produced under the same conditions, but without application of the present invention. According to the present invention, it is preferred that the yield be increased by at least 0.5%, more preferred at least 1%, even more preferred at least 2%, still more preferred at least 4% , preferably 5% or even more.
  • any or all of the above crop enhancements may also lead to an improved utilisation of land, i.e. land which was previously unavailable or sub-optimal for cultivation may become available.
  • land i.e. land which was previously unavailable or sub-optimal for cultivation
  • plants which show an increased ability to survive in drought conditions may be able to be cultivated in areas of sub-optimal rainfall, e.g. perhaps on the fringe of a desert or even the desert itself.
  • crop enhancements are made in the substantial absence of pressure from pests and/or diseases and/or abiotic stress.
  • improvements in plant vigour, stress tolerance, quality and/or yield are made in the substantial absence of pressure from pests and/or diseases.
  • pests and/or diseases may be controlled by a pesticidal treatment that is applied prior to, or at the same time as, the method of the present invention.
  • improvements in plant vigour, stress tolerance, quality and/or yield are made in the absence of pest and/or disease pressure.
  • improvements in plant vigour, quality and/or yield are made in the absence, or substantial absence, of abiotic stress.
  • the compounds of the present invention can be used alone, but are generally formulated into compositions using formulation adjuvants, such as carriers, solvents and surface-active agents (SFAs).
  • formulation adjuvants such as carriers, solvents and surface-active agents (SFAs).
  • the present invention further provides a composition comprising a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • a composition consisting essentially of a compound of the present invention and an agriculturally acceptable formulation adjuvant There is also provided a composition consisting of a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • the present disclosure further provides a plant growth regulator composition comprising a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • a plant growth regulator composition consisting essentially of a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • a plant growth regulator composition consisting of a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • the present disclosure further provides a plant abiotic stress management composition comprising a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • a plant abiotic stress management composition comprising essentially of a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • a plant abiotic stress management composition consisting of a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • the present disclosure further provides a seed germination inhibitor composition comprising a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • a seed germination inhibitor composition consisting essentially of a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • a seed germination inhibitor composition consisting of a compound of the present invention and an agriculturally acceptable formulation adjuvant.
  • composition can be in the form of concentrates which are diluted prior to use, although ready-to-use compositions can also be made.
  • the final dilution is usually made with water, but can be made instead of, or in addition to, water, with, for example, liquid fertilisers, micronutrients, biological organisms, oil or solvents.
  • compositions generally comprise from 0.1 to 99 % by weight, especially from 0.1 to 95 % by weight, compounds of the present invention and from 1 to 99.9 % by weight of a formulation adjuvant which preferably includes from 0 to 25 % by weight of a surface-active substance.
  • a formulation adjuvant which preferably includes from 0 to 25 % by weight of a surface-active substance.
  • the compositions can be chosen from a number of formulation types, many of which are known from the Manual on Development and Use of FAO Specifications for Plant Protection Products, 5th Edition, 1999 .
  • DP dustable powders
  • SP soluble powders
  • SG water soluble granules
  • WP water dispersible granules
  • GR granules
  • SL soluble concentrates
  • OL oil miscible liquids
  • UL ultralow volume liquids
  • EC emulsifiable concentrates
  • DC dispersible concentrates
  • ME micro-emulsions
  • SC suspension concentrates
  • aerosols capsule suspensions
  • CS seed treatment formulations.
  • the formulation type chosen in any instance will depend upon the particular purpose envisaged and the physical, chemical and biological properties of the compound of the present invention.
  • Dustable powders may be prepared by mixing a compound of the present invention with one or more solid diluents (for example natural clays, kaolin, pyrophyllite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulphur, lime, flours, talc and other organic and inorganic solid carriers) and mechanically grinding the mixture to a fine powder.
  • solid diluents for example natural clays, kaolin, pyrophyllite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulphur, lime, flours, talc and other organic and inorganic solid carriers
  • Soluble powders may be prepared by mixing a compound of the present invention with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulphate) or one or more water-soluble organic solids (such as a polysaccharide) and, optionally, one or more wetting agents, one or more dispersing agents or a mixture of said agents to improve water dispersibility/solubility. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water soluble granules (SG).
  • water-soluble inorganic salts such as sodium bicarbonate, sodium carbonate or magnesium sulphate
  • water-soluble organic solids such as a polysaccharide
  • wetting agents such as sodium bicarbonate, sodium carbonate or magnesium sulphate
  • dispersing agents such as sodium bicarbonate, sodium carbonate or magnesium sulphate
  • SG water soluble granules
  • WP Wettable powders
  • WG Water dispersible granules
  • Granules may be formed either by granulating a mixture of a compound of the present invention and one or more powdered solid diluents or carriers, or from pre-formed blank granules by absorbing a compound of the present invention (or a solution thereof, in a suitable agent) in a porous granular material (such as pumice, attapulgite clays, fuller's earth, kieselguhr, diatomaceous earths or ground corn cobs) or by adsorbing a compound of the present invention (or a solution thereof, in a suitable agent) on to a hard core material (such as sands, silicates, mineral carbonates, sulphates or phosphates) and drying if necessary.
  • a hard core material such as sands, silicates, mineral carbonates, sulphates or phosphates
  • Agents which are commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters) and sticking agents (such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils).
  • solvents such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters
  • sticking agents such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils.
  • One or more other additives may also be included in granules (for example an emulsifying agent, wetting agent or dispersing agent).
  • DC Dispersible Concentrates
  • a compound of the present invention may be prepared by dissolving a compound of the present invention in water or an organic solvent, such as a ketone, alcohol or glycol ether.
  • organic solvent such as a ketone, alcohol or glycol ether.
  • surface active agent for example to improve water dilution or prevent crystallisation in a spray tank.
  • Emulsifiable concentrates or oil-in-water emulsions (EW) may be prepared by dissolving a compound of the present invention in an organic solvent (optionally containing one or more wetting agents, one or more emulsifying agents or a mixture of said agents).
  • Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark), ketones (such as cyclohexanone or methylcyclohexanone) and alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N-alkylpyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethyl amides of fatty acids (such as C 8 -C 10 fatty acid dimethylamide) and chlorinated hydrocarbons.
  • aromatic hydrocarbons such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark
  • ketones such as cycl
  • An EC product may spontaneously emulsify on addition to water, to produce an emulsion with sufficient stability to allow spray application through appropriate equipment.
  • Preparation of an EW involves obtaining a compound of the present invention either as a liquid (if it is not a liquid at room temperature, it may be melted at a reasonable temperature, typically below 70°C) or in solution (by dissolving it in an appropriate solvent) and then emulsifying the resultant liquid or solution into water containing one or more SFAs, under high shear, to produce an emulsion.
  • Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzenes), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other appropriate organic solvents which have a low solubility in water.
  • Microemulsions may be prepared by mixing water with a blend of one or more solvents with one or more SFAs, to produce spontaneously a thermodynamically stable isotropic liquid formulation.
  • a compound of the present invention is present initially in either the water or the solvent/SFA blend.
  • Suitable solvents for use in MEs include those hereinbefore described for use in ECs or in EWs.
  • An ME may be either an oil-in-water or a water-in-oil system (which system is present may be determined by conductivity measurements) and may be suitable for mixing water-soluble and oil-soluble pesticides in the same formulation.
  • An ME is suitable for dilution into water, either remaining as a microemulsion or forming a conventional oil-in-water emulsion.
  • SC Suspension concentrates
  • SCs may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of the present invention.
  • SCs may be prepared by ball or bead milling the solid compound of the present invention in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound.
  • One or more wetting agents may be included in the composition and a suspending agent may be included to reduce the rate at which the particles settle.
  • a compound of the present invention may be dry milled and added to water, containing agents hereinbefore described, to produce the desired end product.
  • Aerosol formulations comprise a compound of the present invention and a suitable propellant (for example n -butane).
  • a compound of the present invention may also be dissolved or dispersed in a suitable medium (for example water or a water miscible liquid, such as n -propanol) to provide compositions for use in non-pressurised, hand-actuated spray pumps.
  • Capsule suspensions may be prepared in a manner similar to the preparation of EW formulations but with an additional polymerisation stage such that an aqueous dispersion of oil droplets is obtained, in which each oil droplet is encapsulated by a polymeric shell and contains a compound of the present invention and, optionally, a carrier or diluent therefor.
  • the polymeric shell may be produced by either an interfacial polycondensation reaction or by a coacervation procedure.
  • the compositions may provide for controlled release of the compound of the present invention and they may be used for seed treatment.
  • a compound of the present invention may also be formulated in a biodegradable polymeric matrix to provide a slow, controlled release of the compound.
  • the composition may include one or more additives to improve the biological performance of the composition, for example by improving wetting, retention or distribution on surfaces; resistance to rain on treated surfaces; or uptake or mobility of a compound of the present invention.
  • additives include surface active agents (SFAs), spray additives based on oils, for example certain mineral oils or natural plant oils (such as soy bean and rape seed oil), and blends of these with other bio-enhancing adjuvants (ingredients which may aid or modify the action of a compound of the present invention).
  • Wetting agents, dispersing agents and emulsifying agents may be SFAs of the cationic, anionic, amphoteric or non-ionic type.
  • Suitable SFAs of the cationic type include quaternary ammonium compounds (for example cetyltrimethyl ammonium bromide), imidazolines and amine salts.
  • Suitable anionic SFAs include alkali metals salts of fatty acids, salts of aliphatic monoesters of sulphuric acid (for example sodium lauryl sulphate), salts of sulphonated aromatic compounds (for example sodium dodecylbenzenesulphonate, calcium dodecylbenzenesulphonate, butylnaphthalene sulphonate and mixtures of sodium di- iso propyl- and tri- iso propyl-naphthalene sulphonates), ether sulphates, alcohol ether sulphates (for example sodium laureth-3-sulphate), ether carboxylates (for example sodium laureth-3-carboxylate), phosphate esters (products from the reaction between one or more fatty alcohols and phosphoric acid (predominately mono-esters) or phosphorus pentoxide (predominately di-esters), for example the reaction between lauryl alcohol and tetraphosphoric acid; additionally
  • Suitable SFAs of the amphoteric type include betaines, propionates and glycinates.
  • Suitable SFAs of the non-ionic type include condensation products of alkylene oxides, such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long chain fatty acids or hexitol anhydrides; condensation products of said partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; simple esters (for example fatty acid polyethylene glycol esters); amine oxides (for example lauryl dimethyl amine oxide); and lecithins.
  • alkylene oxides such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof
  • fatty alcohols such as oleyl alcohol or cetyl alcohol
  • alkylphenols such as octylphenol, nonyl
  • Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite).
  • hydrophilic colloids such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose
  • swelling clays such as bentonite or attapulgite
  • the compound or composition of the present invention may be applied to a plant, part of the plant, plant organ, plant propagation material or a plant growing locus.
  • plants refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits.
  • locus means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation.
  • plant propagation material denotes all generative parts of a plant, for example seeds or vegetative parts of plants such as cuttings and tubers. It includes seeds in the strict sense, as well as roots, fruits, tubers, bulbs, rhizomes, and parts of plants.
  • the application is generally made by spraying the composition, typically by tractor mounted sprayer for large areas, but other methods such as dusting (for powders), drip or drench can also be used.
  • the composition may be applied in furrow or directly to a seed before or at the time of planting.
  • the compound or composition of the present invention may be applied pre-emergence or post-emergence.
  • the composition may be applied post-emergence of the crop.
  • the composition may be applied pre-emergence.
  • the present invention envisages application of the compounds or compositions of the invention to plant propagation material prior to, during, or after planting, or any combination of these.
  • seed would have been harvested from the field; removed from the plant; and separated from any cob, stalk, outer husk, and surrounding pulp or other non-seed plant material. Seed would preferably also be biologically stable to the extent that treatment would not cause biological damage to the seed. It is believed that treatment can be applied to seed at any time between seed harvest and sowing of seed including during the sowing process.
  • Methods for applying or treating active ingredients on to plant propagation material or to the locus of planting include dressing, coating, pelleting and soaking as well as nursery tray application, in furrow application, soil drenching, soil injection, drip irrigation, application through sprinklers or central pivot, or incorporation into soil (broad cast or in band).
  • active ingredients may be applied on a suitable substrate sown together with the plant propagation material.
  • the rates of application of compounds of the present invention may vary within wide limits and depend on the nature of the soil, the method of application (pre- or post-emergence; seed dressing; application to the seed furrow; no tillage application etc.), the crop plant, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop.
  • the compounds of the present invention according to the invention are generally applied at a rate of from 1 to 2000 g/ha, especially from 5 to 1000 g/ha.
  • the rate of application is generally between 0.0005 and 150g per 100kg of seed.
  • Crops of useful plants in which the composition according to the invention can be used include perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St.
  • perennial and annual crops such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries
  • cereals for example barley, maize (corn), mille
  • Augustine grass and Zoysia grass herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.
  • herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme
  • legumes for example beans, lentils, peas and soya beans
  • Crops are to be understood as being those which are naturally occurring, obtained by conventional methods of breeding, or obtained by genetic engineering. They include crops which contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavour).
  • output traits e.g. improved storage stability, higher nutritional value and improved flavour.
  • Crops are to be understood as also including those crops which have been rendered tolerant to herbicides like bromoxynil or classes of herbicides such as ALS-, EPSPS-, GS-, HPPD- and PPO-inhibitors.
  • herbicides like bromoxynil or classes of herbicides such as ALS-, EPSPS-, GS-, HPPD- and PPO-inhibitors.
  • An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield® summer canola.
  • crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I® and LibertyLink®.
  • Crops are also to be understood as being those which naturally are or have been rendered resistant to harmful insects. This includes plants transformed by the use of recombinant DNA techniques, for example, to be capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria. Examples of toxins which can be expressed include ⁇ -endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins of bacteria colonising nematodes, and toxins produced by scorpions, arachnids, wasps and fungi.
  • Vip vegetative insecticidal proteins
  • insecticidal proteins of bacteria colonising nematodes and toxins produced by scorpions, arachnids, wasps and fungi.
  • An example of a crop that has been modified to express the Bacillus thuringiensis toxin is the Bt maize KnockOut® (Syngenta Seeds).
  • An example of a crop comprising more than one gene that codes for insecticidal resistance and thus expresses more than one toxin is VipCot® (Syngenta Seeds).
  • Crops or seed material thereof can also be resistant to multiple types of pests (so-called stacked transgenic events when created by genetic modification).
  • a plant can have the ability to express an insecticidal protein while at the same time being herbicide tolerant, for example Herculex I® (Dow AgroSciences, Pioneer Hi-Bred International).
  • Compounds of the present invention may also be used to inhibit or delay the germination of seeds of non-crop plants, for example as part of an integrated weed control program.
  • a delay in germination of weed seeds may provide a crop seedling with a stronger start by reducing competition with weeds.
  • compounds of the present invention may be used to delay the germination of seeds of crop plants, for example to increase the flexibility of timing of planting for the grower.
  • a grower would use one or more other agronomic chemicals or biologicals in addition to the compound or composition of the present invention.
  • a mixture comprising a compound or composition of the present invention, and a further active ingredient.
  • agronomic chemicals or biologicals include pesticides, such as acaricides, bactericides, fungicides, herbicides, insecticides, nematicides, plant growth regulators, crop enhancing agents, safeners as well as plant nutrients and plant fertilizers.
  • suitable mixing partners may be found in the Pesticide Manual, 15th edition (published by the British Crop Protection Council ). Such mixtures may be applied to a plant, plant propagation material or plant growing locus either simultaneously (for example as a pre-formulated mixture or a tank mix), or sequentially in a suitable timescale. Co-application of pesticides with the present invention has the added benefit of minimising farmer time spent applying products to crops.
  • the combination may also encompass specific plant traits incorporated into the plant using any means, for example conventional breeding or genetic modification.
  • a compound, composition or mixture of the present invention for improving the tolerance of a plant to abiotic stress, regulating or improving the growth of a plant, inhibiting seed germination and/or safening a plant against phytotoxic effects of chemicals.
  • the compounds of the invention may be made by the following methods.
  • Schemes 1-7 provide methods of preparing the compounds of formula (I), compounds of formula (II) and compounds of formula (III) of the present invention, wherein R4, R5, R6, R7 and R8 are H when present.
  • Compounds of formula (VII) are commercially available or can be made by methods known to a person skilled in the art.
  • Compounds of formula (VI) may be prepared from a compound of formula (VII) by reaction with an alkylating agent of formula R1-X, wherein X is a leaving group such as halogen, mesylate, triflate or tosylate.
  • R1-X can be propyl iodide, ethyl iodide, allyl bromide or methyl iodide.
  • Such reactions are usually carried out in the presence of a base, and optionally in the presence of a nucleophilic catalyst.
  • Compounds of formula (VIIa) are commercially available or can be made by methods known to a person skilled in the art.
  • Compounds of formula (VIa) may be prepared from a compound of formula (VIIa) by reaction with an alkylating agent of formula R1-X, wherein X is a leaving group such as halogen, mesylate, triflate or tosylate.
  • R1-X can be propyl iodide, ethyl iodide, allyl bromide or methyl iodide.
  • Such reactions are usually carried out in the presence of a base, and optionally in the presence of a nucleophilic catalyst.
  • Compounds of formula (V), wherein R4, R5 and R6 are H, may be prepared from a compound of formula (VI) by reaction with 2-chloro- N -(hydroxymethyl)acetamide in a solvent such as acetic acid, and optionally in the presence of stronger acid such as sulfuric acid, followed by hydrolysis of the resulting 2-chloroacetamide with an acid such as HCl in an alcoholic solvent.
  • Compound (V) can be obtained as its hydrochloride salt or a free amine after neutralization with a base.
  • Compounds of formula (V), wherein R4 and R5 are H, may be prepared from a compound of formula (VIb) wherein X is a leaving group such as halogen, by reaction with an amine of formula R6NH 2 or its hydrochloride salt of formula R6NH 3 Cl, in the presence or not of a base such as triethyl amine or diisopropylamine.
  • R6NH 2 can be ammonia, methyl amine or ethyl amine.
  • the compound of formula (VIb) may be obtained from a compound of formula (VIa) wherein X is a leaving group such as Cl or Br, by radical reaction with N-bromosuccinimide or N-chlorosuccinimide in the presence of an initiator such as AlBN or dibenzoyl peroxide.
  • X is a leaving group such as Cl or Br
  • Compounds of formula (V), wherein R4, R5 and R6 are H, may be prepared from a compound of formula (VIII) by reduction of the cyano moiety under hydrogen atmosphere in the presence of a catalyst such as palladium on charcoal, or by reducing agent such as sodium borohydride in the presence of a catalyst such as nickel chloride or cobalt chloride for example.
  • the compound of formula (VIII) may be obtained from a compound of formula (IX) wherein X is a leaving group such as Cl or Br, I or OTf by a coupling reaction with a cyanide salt such as CuCN, NaCN, K 3 [Fe(CN) 6 ], in the presence or not of a catalyst such as palladium (0) or copper, eventually with an additional ligand as described in the literature (see Zanon et al, J. Am. Chem Soc. 2003, 125, 2890-2891 , Buchwald, S & all, Angew. Chem. Int. Ed. 2013, 52: 10035-10039 ).
  • the compound of formula (IX) may be obtained from a compound of formula (IXa) by reaction with an alkylating agent of formula R1-X, wherein X is a leaving group such as halogen, mesylate, triflate or tosylate.
  • R1-X can be propyl iodide, ethyl iodide, allyl bromide, or methyl iodide.
  • Such reactions are usually carried out in the presence of a base, and optionally in the presence of a nucleophilic catalyst.
  • compound of formula (VIII) may be obtained from a compound of formula (VIIIa) by reaction with an alkylating agent of formula R1-X, wherein X is a leaving group such as halogen, mesylate, triflate or tosylate.
  • R1-X can be propyl iodide, ethyl iodide, allyl bromide, or methyl iodide. Such reactions are usually carried out in the presence of a base, and optionally in the presence of a nucleophilic catalyst.
  • Compound of formula (VIIIa) may be prepared from compound (IXa) wherein X is a leaving group such as Cl or Br, I or OTf by a coupling reaction with a cyanide salt as described for compound (VIIIa)
  • Compounds of formula (V) wherin R5 is H, may be prepared from a compound of formula (X) by amino reduction of the carbonyl moiety in the presence of an amine of formula R6NH 2 or its corresponding salt in the presence of a reducing agent such as sodium cyanoborohydride and eventually of an additional organic acid such as acetic acid.
  • a reducing agent such as sodium cyanoborohydride and eventually of an additional organic acid such as acetic acid.
  • the compound of formula (X) may be obtained from a compound of formula (Xa) by reaction with an alkylating agent of formula R1-X, wherein X is a leaving group such as halogen, mesylate, triflate or tosylate.
  • R1-X can be propyl iodide, ethyl iodide, allyl bromide, or methyl iodide. Such reactions are usually carried out in the presence of a base, and optionally in the presence of a nucleophilic catalyst.
  • Compounds of formula (I) may be prepared from a compound of formula (V) by reaction with sulfonyl chloride of formula A-L-SO 2 Cl. Such reactions are usually carried out in the presence of an organic base, such as N -ethyldiisopropylamine.
  • A-L-SO 2 Cl can be benzenesulfonyl chloride, benzylsulfonyl chloride or butylsulfonyl chloride.
  • Compounds of formula A-L-SO 2 Cl are commercially available or can be made by methods known to a person skilled in the art.
  • 6-(aminomethyl)-1-propyl-3,4-dihydroquinolin-2-one (0.055 g, 0.216 mmol) was stirred in EtOAc (4 mL). The reaction mixture was cooled on ice. Diisopropylethylamine (0.132 mL, 0.756 mmol) was added and then 2,4-dimethylbenzenesulfonyl chloride (0.059 g, 0.281 mmol). The reaction mixture was stirred 3 h at 50 °C. The reaction mixture was concentrated.
  • 6-Methyl-1H-quinolin-2-one (5.00 g, 31.41 mmol) was dissolved in DMF (50 mL). Potassium carbonate (8.68 g, 62.8 mmol) was added, followed by 1-bromopropane (19.3 g, 157 mmol, 14.3 mL). The reaction mixture was stirred overnight at room temperature and then poured into 200 mL of ice-water. The water-phase was extracted with ethyl acetate and the combined organic phases were washed with water and brine. The organic phase was dried with Na 2 SO 4 , filtrated and concentrated to give 9.1 g of pale yellow oil.
  • 6-Methyl-1-propyl-quinolin-2-one (2.5 g, 12 mmol) was dissolved in asolution of carbon tetrachloride (5 mL) and 1-bromopyrrolidine-2,5-dione (2.5 g, 14 mmol).
  • the reaction mixture was stirred and heated at 80 °C then azobisisobutyronitrile (0.2 g, 1.2 mmol) was added.
  • the resulting solution was stirred at 80 °C for 6 h and cooled. Water was added and the mixture was extracted with ethyl acetate. The combined organic phases were washed with brine, dried with Na 2 SO 4 , filtrated and concentrated to give 0.61 g of brown oil.
  • 6-(Bromomethyl)-1-propyl-quinolin-2-one (1.6 g, 5.7 mmol) was dissolved in a solution of NH 3 /MeOH (41 mL, 7 mol/L). The yellow solution was stirred for overnight, after complete conversion the solution was concentrated on vacuum and purified on silica gel to give 6-(aminomethyl)-1-propyl-quinolin-2-one (710 mg, 3.28 mmol, 57%); 1 H NMR (400 MHz, MeOH) ⁇ ppm 1.03 (t, 3 H), 1.72 - 1.81 (m, 2H), 4.20 (s, 2 H), 4.29 - 4.35 (m, 2 H), 6.72 (d, 1 H), 7.66 - 7.74 (m, 2 H), 7.78 (d, 1 H), 7.92 (d, 1 H); LC-MS (Method A): RT 0.26, (218, M+H + ).
  • 6-Acetyl-3,4-dihydro-1H-quinolin-2-one 500 mg, 2.64 mmol was dissolved in DMF (5 mL) and potassium carbonate (0.547 g, 3.96 mmol) was added followed by 1-bromopropane (0.487 g, 3.96 mmol, 0,36 mL). The reaction mixture was stirred overnight at room temperature and more potassium carbonate (0.550 g, 1.5 eq.) and 1-bromopropane (0.18 mL, 0.75 eq.) were added. The reaction mixture was heated at 50 °C until to have a complete conversion, cooled to room temperature and poured into ice-water. The water-phase was extracted with ethyl acetate.
  • 6-Acetyl-1-propyl-3,4-dihydroquinolin-2-one (480 mg, 2.08 mmol) was dissolved in methanol (7 mL, 2.08 mmol) then ammonium acetate (1.62 g, 20.8 mmol) and sodium cyanoborohydride (0.686 g, 10.4 mmol) were added .
  • the reaction mixture was stirred at room temperature overnight.
  • the solvent was removed under reduced pressure and the residue was dissolved in ethyl acetate and acidified with 2M HCl (until pH: 2).
  • the organic layer was discarded.
  • the aqueous layer was treated with 2M NaOH (until pH: 12) and extracted 3x with ethyl acetate.
  • 6-(1-Aminoethyl)-1-propyl-3,4-dihydroquinolin-2-one (0.050 g, 0.215 mmol) was stirred in EtOAc (2 mL). The reaction mixture was cooled on ice. Diisopropylethylamine (0.093 mL, 0.538 mmol) was added and then benzenesulfonyl chloride (0.039 g, 0.215 mmol). The reaction mixture was stirred overnight and concentrated. The crude product was purified on silica gel to give N-[(2-oxo-1-propyl-6-quinolyl)methyl]benzenesulfonamide (49 mg, 61 % yield) as a colourless gum.
  • 6-(1-Aminocyclopropyl)-1-propyl-3,4-dihydroquinolin-2-one (0.050 g, 0.204 mmol) was stirred in EtOAc (2 mL). The reaction mixture was cooled on ice. Diisopropylethylamine (0.087 mL, 0.511 mmol) was added and then benzenesulfonyl chloride (0.037 g, 0.204 mmol). The reaction mixture was stirred overnight and concentrated.
  • 6-(Aminomethyl)-1-(2,2,2-trifluoroethyl)-3,4-dihydroquinolin-2-one hydrochloride (0.150 g, 0.509 mmol) was suspended in ethyl acetate (5 mL) and N -ethyl- N -isopropyl-propan-2-amine (0.218 mL, 1.27 mmol) was added dropwise. Then benzenesulfonyl chloride (0.102 g, 0.560 mmol) was added dropwise and the reaction mixture was stirred for 3 h at room temperature.
  • 6-(Aminomethyl)-1-(3-pyridyl)-3,4-dihydroquinolin-2-one dihydrochloride (0.163 g, 0.50 mmol) was suspend in ethyl acetate (6.5 mL) with diisopropylethylamine (0.226 g, 1.75 mmol) and stirred at room temperature during 15 min. Benzenesulfonyl chloride (0.115 g, 0.65 mmol) was added and reaction mixture was stirred over the weekend at room temperature. Water was added and extracted two times with ethyl acetate.
  • Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150°C, Desolvation Temperature: 350°C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector.
  • Spectra were recorded on a Mass Spectrometer from Waters SQD 2 equipped with an electrospray source (Polarity: positive ions, Capillary: 3.5 kV, Cone range: 30 V, Extractor: 3.00 V, Source Temperature: 150°C, Desolvation Temperature: 400°C, Cone Gas Flow: 60 L/Hr, Desolvation Gas Flow: 700 L/Hr, Mass range: 140 to 800 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector.
  • results are expressed compared to negative control treatment (diluted EC formulation without active ingredient but with EXTRAVON 1g/20L).
  • WU is measured within day time (chamber light is on 06:00 to 20:00) at these timepoints: 0 DAA a.m. (10:30-12:50), 0 DAA p.m. (14:00-19:50), 1 DAA a.m. (07:30-12:50), 1 DAA p.m. (14:00-19:50), 2 DAA a.m. (07:30-12:50) and 2 DAA p.m. (14:00-19:50).
  • the culmulative total WU (0-2.5 DAA) is calculated by summing the WU data mentioned above.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cultivation Of Plants (AREA)
  • Quinoline Compounds (AREA)

Claims (14)

  1. Composé de formule (I)
    Figure imgb0047
     dans lequel :
    R1 est choisi dans le groupe constitué par C1-C7 alkyle, C1-C7 halogénoalkyle, C3-C5 cycloalkyl-C1-C7 alkyle, C3-C7 alcényle, C3-C7 alcynyle, aryl-C1-C7 alkyle, (hétérocyclyle de 3-6 chaînons)-C1-C7 alkyle, phényle, C3-C5 cycloalkyle et hétérocyclyle de 4-6 chaînons, chacun éventuellement substitué par de un à trois Rx ;
    R2 est choisi dans le groupe constitué par hydrogène, cyano, C1-C4 alkyle, C1-C4 alcoxy, C1-C4 halogénoalkyle, C1-C4 halogénoalcoxy et C3-C4 cycloalkyle ;
    R3, R7 et R8 sont choisis indépendamment dans le groupe constitué par hydrogène, halogène, cyano, C1-C4 alkyle, C2-C4 alcényle, C2-C4 alcynyle, C1-C4 alcoxy, C1-C4 halogénoalkyle, C1-C4 halogénoalcoxy et C3-C4 cycloalkyle ;
    R4 et R5 sont choisis indépendamment dans le groupe constitué par hydrogène, C1-C4 alkyle, C1-C4 halogénoalkyle et C3-C4 cycloalkyle ;
    ou R4 et R5 peuvent former, conjointement avec l'atome ou les atomes auxquels ils sont directement fixés, C3-C4 cycloalkyle ou C4 hétérocyclyle ;
    R6 est choisi dans le groupe constitué par hydrogène, C1-C4 alkyle, C3-C4 alcényle, C3-C4 alcynyle, et C1-C3 alcoxy-C1-C4-alkyle ;
    L est choisi dans le groupe constitué par une liaison, une chaîne -C1-C4- alkyle linéaire, une chaîne -C2-C4- alcényle linéaire, une chaîne -C2-C4-alcynyle linéaire, une chaîne -C1-C4- alcoxy linéaire où l'atome d'oxygène est fixé à A, une chaîne -amino-C1-C4-alkyl- linéaire où l'atome d'azote est fixé à A, et une chaîne C1-C2alkyloxy-C1-C2alkyle linéaire, chacune éventuellement substituée par de un à trois parmi halogène, cyano, C1-C4 alkyle, C1-C4 halogénoalkyle ou C1-C4 alcoxy ;
    A est hydrogène, C1-C7 alkyle, C3-C5 cycloalkyle, hétérocyclyle de 3-10 chaînons ou aryle, chacun éventuellement substitué par de un à trois Ry ;
    Rx est, indépendamment les uns des autres, choisi dans le groupe constitué par halogène, cyano, C1-C4 alkyle, C1-C4 halogénoalkyle, C1-C4 alcoxy, C1-C4 halogénoalcoxy, C1-C4 alkylcarbonyle, C1-C4 alcoxycarbonyle, acide carboxylique, aminocarbonyle, C1-C4 aminocarbonyle et C3-C4 cycloalkyle ;
    Ry est, indépendamment les uns des autres, choisi dans le groupe constitué par halogène, cyano, nitro, C1-C4 alkyle, C1-C4 alcoxy, C1-C4 halogénoalkyle, C1-C4 halogénoalkyloxy, C1-C4 alkylsulfanyle, C1-C4 halogénoalkylsulfanyle, C1-C4 alkylsulfinyle, C1-C4 halogénoalkylsulfinyle, C1-C4 alkylsulfonyle, C1-C4 halogénoalkylsulfonyle, C1-C4 alkylcarbonyle, C1-C4 alcoxycarbonyle, acide carboxylique, aminocarbonyle, C1-C4 aminocarbonyle et C3-C4 cycloalkyle, lequel cycloalkyle est non substitué ou substitué par un ou plusieurs Rz ;
    Rz est choisi indépendamment dans le groupe constitué par halogène, C1-C4-alkyle et C1-C4-halogénoalkyle ;
    où A n'est pas butyle lorsque R4 ou bien R5 est méthyle ;
    et où R1 n'est pas méthyle lorsque R2, R3, R4, R5, R6, R7 et R8 sont chacun hydrogène ;
    ou des sels ou N-oxydes de celui-ci.
  2. Composé selon la revendication 1, dans lequel R1 est choisi dans le groupe constitué par C1-C6 alkyle, C1-C6 halogénoalkyle, C3-C6 alcényle et C3-C5 cyclopropyl-C1-C6-alkyle.
  3. Composé selon la revendication 2, dans lequel R1 est éthyle ou propyle.
  4. Composé selon l'une quelconque des revendications 1 à 3, dans lequel L est une liaison.
  5. Composé selon l'une quelconque des revendications 1 à 4, dans lequel A est choisi dans le groupe constitué par C1-C7 alkyle, phényle et hétéroaryle de 3-6 chaînons, chacun éventuellement substitué par de un à trois Ry.
  6. Composé selon la revendication 5, dans lequel A est phényle éventuellement substitué par de un à trois substituants choisis indépendamment dans le groupe constitué par halogène, C1-C4 halogénoalkyle, C1-C4 alkyle et C1-C4 halogénoalcoxy.
  7. Composé selon l'une quelconque des revendications précédentes, dans lequel R2 est choisi dans le groupe constitué par hydrogène et C1-C4 alkyle.
  8. Composé selon l'une quelconque des revendications précédentes, dans lequel R3 est choisi dans le groupe constitué par hydrogène, halogène et C1-C4 alkyle.
  9. Composé selon l'une quelconque des revendications précédentes, dans lequel R2, R3, R4, R5, R6, R7 et R8 sont hydrogène.
  10. Composition comprenant un composé selon l'une quelconque des revendications précédentes, et un adjuvant de formulation acceptable sur le plan agricole.
  11. Mélange comprenant un composé tel que défini selon l'une quelconque des revendications précédentes, et un autre ingrédient actif.
  12. Méthode d'amélioration de la tolérance d'une plante vis-à-vis d'un stress abiotique, où la méthode comprend l'application à la plante, à une partie de plante, à un matériel de propagation végétal, ou à un lieu où se développent des plantes, d'un composé selon l'une quelconque des revendications 1 à 9, d'une composition selon la revendication 10, ou d'un mélange selon la revendication 11.
  13. Méthode d'inhibition de la germination des graines d'une plante, où la méthode comprend l'application à la plante, à une partie de plante, à un matériel de propagation végétal, ou à un lieu où se développent des plantes, d'un composé selon l'une quelconque des revendications 1 à 9, d'une composition selon la revendication 10, ou d'un mélange selon la revendication 11.
  14. Méthode de régulation ou d'amélioration de la croissance d'une plante, où la méthode comprend l'application à la plante, à une partie de plante, à un matériel de propagation végétal, ou à un lieu où se développent des plantes, d'un composé selon l'une quelconque des revendications 1 à 9, d'une composition selon la revendication 10, ou d'un mélange selon la revendication 11.
EP16703127.7A 2015-02-09 2016-02-05 Composés 2-oxo-3,4-dihydroquinoléine à utiliser en tant que régulateurs de croissance des plantes Active EP3256447B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL16703127T PL3256447T3 (pl) 2015-02-09 2016-02-05 Związki 2-okso-3,4-dihydrochinoliny jako regulatory wzrostu roślin
HRP20191504 HRP20191504T1 (hr) 2015-02-09 2019-08-21 Spojevi 2-okso-3,4-dihidrokinolina kao regulatori rasta biljaka

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1502067.0A GB201502067D0 (en) 2015-02-09 2015-02-09 Plant growth regulator compounds
GBGB1509129.1A GB201509129D0 (en) 2015-05-28 2015-05-28 Plant growth regulator compounds
PCT/EP2016/052492 WO2016128317A1 (fr) 2015-02-09 2016-02-05 Composés 2-oxo-3,4-dihydroquinoléine à utiliser en tant que régulateurs de croissance des plantes

Publications (2)

Publication Number Publication Date
EP3256447A1 EP3256447A1 (fr) 2017-12-20
EP3256447B1 true EP3256447B1 (fr) 2019-06-05

Family

ID=55304997

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16703127.7A Active EP3256447B1 (fr) 2015-02-09 2016-02-05 Composés 2-oxo-3,4-dihydroquinoléine à utiliser en tant que régulateurs de croissance des plantes

Country Status (18)

Country Link
US (1) US10392348B2 (fr)
EP (1) EP3256447B1 (fr)
JP (1) JP6743033B2 (fr)
KR (1) KR20170115053A (fr)
CN (1) CN107207440B (fr)
AU (1) AU2016218073B2 (fr)
BR (1) BR112017016716A2 (fr)
CA (1) CA2974467A1 (fr)
ES (1) ES2743302T3 (fr)
HR (1) HRP20191504T1 (fr)
HU (1) HUE044696T2 (fr)
MX (1) MX2017009623A (fr)
PL (1) PL3256447T3 (fr)
PT (1) PT3256447T (fr)
RU (1) RU2706331C2 (fr)
UA (1) UA121042C2 (fr)
WO (1) WO2016128317A1 (fr)
ZA (1) ZA201704728B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201611717D0 (en) * 2016-07-05 2016-08-17 Syngenta Participations Ag Plant growth regulator compounds
GB201820729D0 (en) 2018-12-19 2019-01-30 Syngenta Participations Ag Plant growth regulator compositions
WO2022167866A1 (fr) * 2021-02-08 2022-08-11 Rappta Therapeutics Oy Modulateurs de la protéine phosphatase 2a (pp2a) et leurs procédés d'utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5173653B2 (ja) * 2007-08-01 2013-04-03 田辺三菱製薬株式会社 医薬組成物
EP2395831B1 (fr) * 2009-02-13 2017-04-12 The Regents of The University of California Régulation de la tolérance au stress des plantes, efficacité d'utilisation de l'eau et expression génétique utilisant de nouvelles protéines de récepteurs d'aba et de nouveaux agonistes synthétiques
US9345245B2 (en) * 2012-03-30 2016-05-24 The Regents Of The University Of California Synthetic compounds for vegetative ABA responses
CN105722825A (zh) * 2013-06-28 2016-06-29 加利福尼亚大学董事会 诱导aba响应的化合物
CN104277000A (zh) * 2014-10-29 2015-01-14 上海绿盎生物科技有限公司 一种脱落酸受体激动剂原药及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
PT3256447T (pt) 2019-09-04
MX2017009623A (es) 2017-11-23
BR112017016716A2 (pt) 2018-06-19
HRP20191504T1 (hr) 2019-11-29
CA2974467A1 (fr) 2016-08-18
AU2016218073A1 (en) 2017-07-27
WO2016128317A1 (fr) 2016-08-18
AU2016218073B2 (en) 2019-12-19
ZA201704728B (en) 2018-08-29
CN107207440B (zh) 2020-11-10
ES2743302T3 (es) 2020-02-18
UA121042C2 (uk) 2020-03-25
CN107207440A (zh) 2017-09-26
RU2017131553A (ru) 2019-03-11
JP2018511562A (ja) 2018-04-26
US20180044297A1 (en) 2018-02-15
EP3256447A1 (fr) 2017-12-20
US10392348B2 (en) 2019-08-27
PL3256447T3 (pl) 2019-12-31
RU2017131553A3 (fr) 2019-06-17
RU2706331C2 (ru) 2019-11-18
JP6743033B2 (ja) 2020-08-19
KR20170115053A (ko) 2017-10-16
HUE044696T2 (hu) 2019-11-28

Similar Documents

Publication Publication Date Title
EP3180313B1 (fr) Composés sulfonamides de 2-oxo-3,4-dihydroquinoline et leur utilisation comme régulateurs de croissance végétale
WO2016022915A1 (fr) Composés 6-sulfonylamino quinoléine utiles en tant que régulateurs de la croissance des plantes
EP3256447B1 (fr) Composés 2-oxo-3,4-dihydroquinoléine à utiliser en tant que régulateurs de croissance des plantes
EA024229B1 (ru) Соединения, регулирующие рост растений
AU2016307240A1 (en) Plant growth regulator compounds
AU2019235282A1 (en) Plant growth regulator compounds
AU2018217789B2 (en) Germination promoters
EP3481202B1 (fr) Composés régulateurs de croissance végétale
US11332443B2 (en) Derivatives of halo quinabactin

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170911

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180718

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20181210

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAR Information related to intention to grant a patent recorded

Free format text: ORIGINAL CODE: EPIDOSNIGR71

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

INTC Intention to grant announced (deleted)
AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

INTG Intention to grant announced

Effective date: 20190426

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1139845

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190615

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016014776

Country of ref document: DE

REG Reference to a national code

Ref country code: HR

Ref legal event code: TUEP

Ref document number: P20191504T

Country of ref document: HR

REG Reference to a national code

Ref country code: RO

Ref legal event code: EPE

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Ref document number: 3256447

Country of ref document: PT

Date of ref document: 20190904

Kind code of ref document: T

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20190816

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20191003 AND 20191009

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190905

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: SYNGENTA PARTICIPATIONS AG

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E044696

Country of ref document: HU

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

REG Reference to a national code

Ref country code: HR

Ref legal event code: T1PR

Ref document number: P20191504

Country of ref document: HR

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20190402563

Country of ref document: GR

Effective date: 20191128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20191504

Country of ref document: HR

Payment date: 20200128

Year of fee payment: 5

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2743302

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20200218

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191005

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016014776

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

26N No opposition filed

Effective date: 20200306

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

REG Reference to a national code

Ref country code: AT

Ref legal event code: UEP

Ref document number: 1139845

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190605

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200205

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200205

REG Reference to a national code

Ref country code: HR

Ref legal event code: ODRP

Ref document number: P20191504

Country of ref document: HR

Payment date: 20210202

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20210126

Year of fee payment: 6

Ref country code: IT

Payment date: 20210211

Year of fee payment: 6

Ref country code: FR

Payment date: 20210120

Year of fee payment: 6

Ref country code: CZ

Payment date: 20210119

Year of fee payment: 6

Ref country code: PT

Payment date: 20210125

Year of fee payment: 6

Ref country code: RO

Payment date: 20210202

Year of fee payment: 6

Ref country code: NL

Payment date: 20210115

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20210113

Year of fee payment: 6

Ref country code: GB

Payment date: 20210129

Year of fee payment: 6

Ref country code: HU

Payment date: 20210123

Year of fee payment: 6

Ref country code: ES

Payment date: 20210301

Year of fee payment: 6

Ref country code: BG

Payment date: 20210115

Year of fee payment: 6

Ref country code: AT

Payment date: 20210126

Year of fee payment: 6

Ref country code: TR

Payment date: 20210203

Year of fee payment: 6

Ref country code: PL

Payment date: 20210119

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: HR

Payment date: 20210202

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190605

REG Reference to a national code

Ref country code: HR

Ref legal event code: PBON

Ref document number: P20191504

Country of ref document: HR

Effective date: 20220205

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602016014776

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20220301

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 1139845

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220205

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20220205

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220205

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220805

Ref country code: HR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220205

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220905

Ref country code: CZ

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220205

Ref country code: BG

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220831

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220205

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220206

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220301

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220205

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220901

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20230327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220206

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220205

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220205